Zengxiang Wu Selected Research

Cholesterol

1/2021

Efficacy and Safety of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zengxiang Wu Research Topics

Disease

1	Renal hypouricemia 01/2024
1	Abscess 01/2023
1	Sarcopenia 01/2023
1	Paranoid Personality Disorder 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Body Weight (Weight, Body) 01/2021

Drug/Important Bio-Agent (IBA)

1	Uric Acid (Urate)IBA 01/2024
1	Moxifloxacin (Avelox)FDA Link 01/2023
1	SDMIBA 01/2023
1	Tuberculin (PPD)IBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021
1	Alanine Transaminase (SGPT)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	CholesterolIBA 01/2021

Therapy/Procedure

1	Contraindications 01/2021